First‐in‐human outpatient management of recurrent NMIBC with the Multi4 instrument
Miden Melle‐Hannah, Henrik Kjölhede, Henrik Bäckdahl, Martin E. Johansson, Joakim Håkansson · 2026
Read First‐in‐human outpatient management of recurrent NMIBC with the Multi4 instrument by Miden Melle‐Hannah, Henrik Kjölhede, Henrik Bäckdahl, Martin E. Johansson, Joakim Håkansson (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13655195.txt.
Description
Miden Melle-Hannah and four co-authors tested in 2026 a device that treats returning bladder cancer in a clinic room instead of an operating theater. This cancer returns often, and each return usually means surgery under full anesthesia, a heavy load for patients and hospitals. The device joins numbing, tissue sampling, and bleeding control in one tool.
Animal tests came first, then a first use in humans under local numbing. The main question was whether clinic samples stay good enough for lab diagnosis. The team also tracked safety, ease of use, patient views, and cost. A workable clinic option could free operating rooms for harder cases.
Catalog record
| CREATOR | Miden Melle‐Hannah, Henrik Kjölhede, Henrik Bäckdahl, Martin E. Johansson, Joakim Håkansson |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 31 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |